Every time an AI alert is sent,Tailin Bio (SZ 300813, closing price: 83.33 yuan) released its annual performance report on the evening of April 18, saying that the operating income in 2021 will be about 283 million yuan, a year-on-year increase of 41.46%; the net profit attributable to shareholders of the listed company is about 63.53 million yuan , an increase of 31.3% year-on-year; basic earnings per share were 1.22 yuan, an increase of 28.42% year-on-year. It is proposed to distribute cash dividends of 3 yuan (tax included) for every 10 shares, not to send bonus shares, and to transfer 6 shares for every 10 shares to all shareholders with the capital reserve.
1. In the past 30 days, no institution has conducted research on Tailin Bio.
(Reporter Jia Yunke)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Do so at your own risk.
Copyright Notice
1This article is an original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, excerpting, copying or creating mirror images, etc. Violators will be held accountable.
3Copyright cooperation telephone: 021-60900099.